Global Active Pharmaceutical Ingredients Market Report 2023: Sector is Expected to Reach $386.2 Billion by 2032 at a CAGR of 6.4% - Yahoo Finance

DUBLIN, May 4, 2023 /PRNewswire/ -- The "Global Active Pharmaceutical Ingredients Market 2022-2032 by Molecule, Synthesis, Manufacturing Process, Therapeutic Application, Drug Type, and Region: Trend Forecast and Growth Opportunity" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

The global active pharmaceutical ingredients (API) market will reach $ 386.2 billion by 2032, growing by 6.4% annually over 2022-2032, driven by rising adoption of biologics in disease management, increasing regulatory approvals, patent expiration of major drugs, growing trend of outsourcing and increase in geriatric population.

Companies Mentioned

• AbbVie Inc.

• AstraZeneca

• Aurobindo Pharma Ltd.

• BASF

• Bayer AG

• Boehringer Ingelheim

• Catalent Inc.

• Dr. Reddy's Laboratories

• F. Hoffmann-La Roche

• GlaxoSmithKline plc

• Lonza Group

• Lupin Limited

• Merck & Co., Inc.

• Mylan NV

• Novartis International AG

• Pfizer Inc.

• Sanofi

• Sun Pharmaceutical Industries Ltd.

• Teva Pharmaceutical Industries Ltd.

• Thermo Fisher Scientific

This report is based on a comprehensive research of the entire global active pharmaceutical ingredients (API) market and all its sub-segments through extensively detailed classifications.

Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2020-2022 and provides forecast from 2023 till 2032 with 2022 as the base year.

In-depth qualitative analyses include identification and investigation of the following aspects:

The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify global active pharmaceutical ingredients (API) market in every aspect of the classification from perspectives of Molecule, Synthesis, Manufacturing Process, Therapeutic Application, Drug Type, and Region.

Based on Molecule, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.

• Small Molecule APIs

• Large Molecule APIs

Based on Synthesis, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.

Based on Manufacturing Process, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.

• Captive Manufacturing

• Branded Captive API

• Generic Captive API

• Merchant Manufacturing

• by Drug Type

• Branded Merchant API

• Generic Merchant API

• by Drug Synthesis

• Merchant Synthetic API

• Merchant Biotech API

By Therapeutic Application, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.

• Infectious Diseases

• Oncology

• Ophthalmology

• Cardiovascular Disorders

• Central Nervous System

• Pulmonary Disorders

• Orthopedics

• Other Applications

By Drug Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.

Geographically, the following regions together with the listed national/local markets are fully investigated:

• North America (U.S., Canada, and Mexico)

• Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)

• APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)

• South America (Brazil, Chile, Argentina, Rest of South America)

• MEA (UAE, Saudi Arabia, South Africa and Rest of MEA)

For more information about this report visit https://www.researchandmarkets.com/r/wlnebw

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

Cision

View original content:https://www.prnewswire.com/news-releases/global-active-pharmaceutical-ingredients-market-report-2023-sector-is-expected-to-reach-386-2-billion-by-2032-at-a-cagr-of-6-4-301816031.html

SOURCE Research and Markets

Adblock test (Why?)

"ingredients" - Google News
May 05, 2023 at 04:45AM
https://ift.tt/MXDPnHR

Global Active Pharmaceutical Ingredients Market Report 2023: Sector is Expected to Reach $386.2 Billion by 2032 at a CAGR of 6.4% - Yahoo Finance
"ingredients" - Google News
https://ift.tt/ryetW25
Shoes Man Tutorial
Pos News Update
Meme Update
Korean Entertainment News
Japan News Update

Bagikan Berita Ini